Form 4: Solid Biosciences Director Ian F. Smith Reports Stock Transaction
SEC Form 4 Filing
Director Ian F. Smith reported the vesting of restricted stock units into common stock of Solid Biosciences Inc.
Summary
- On April 3, 2024, Ian F. Smith, a director of Solid Biosciences Inc., reported a transaction involving restricted stock units.
- 3,256 restricted stock units vested and converted into 3,256 shares of common stock.
- Following the transaction, Smith directly owns 103,207 shares of common stock and 9,765 restricted stock units.
- The restricted stock units were granted on January 3, 2024, and vest in equal quarterly installments over 12 months.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction, which is neither inherently positive nor negative.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| January 3, 2024 | Grant date of the restricted stock units |
| April 3, 2024 | Date of transaction: vesting of restricted stock units |
| April 5, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.